December 8, 2021 Non Regulatory InDex Pharmaceuticals enrols first patient in the PK study with cobitolimod Read more
December 8, 2021 Non Regulatory InDex Pharmaceuticals inkluderar första patienten i PK-studien med cobitolimod Read more
November 10, 2021 Non Regulatory InDex Pharmaceuticals Holding AB (publ) announces Nomination Committee for the 2022 Annual General Meeting Read more
November 10, 2021 Non Regulatory InDex Pharmaceuticals Holding AB (publ) offentliggör valberedning inför årsstämman 2022 Read more
November 8, 2021 Non Regulatory InDex Pharmaceuticals presents at Redeye Life Science Day 2021 Read more
November 8, 2021 Non Regulatory InDex Pharmaceuticals presenterar på Redeye Life Science Day 2021 Read more
August 23, 2021 Non Regulatory InDex Pharmaceuticals strengthens the clinical development organization in preparation of the start of the phase III study CONCLUDE with cobitolimod Read more
August 23, 2021 Non Regulatory InDex Pharmaceuticals stärker sin kliniska utvecklingsorganisation inför starten av fas III-studien CONCLUDE med cobitolimod Read more
April 7, 2021 Non Regulatory InDex Pharmaceuticals gets patent for additional DIMS compounds granted in Europe Read more
April 7, 2021 Non Regulatory InDex Pharmaceuticals får patent på ytterligare DIMS-substanser beviljat i Europa Read more
March 30, 2021 Non Regulatory InDex Pharmaceuticals enters agreement with Parexel Biotech for phase III clinical study of cobitolimod for ulcerative colitis Read more
March 30, 2021 Non Regulatory InDex Pharmaceuticals ingår avtal med Parexel Biotech för klinisk fas III-studie med cobitolimod Read more
March 15, 2021 Non Regulatory InDex Pharmaceuticals Holding AB (publ) announces changes in the Nomination Committee for the 2021 Annual General Meeting Read more
March 15, 2021 Non Regulatory InDex Pharmaceuticals Holding AB (publ) meddelar förändringar i valberedningens sammansättning inför årsstämman 2021 Read more
March 10, 2021 Non Regulatory InDex Pharmaceuticals presents at Barclays Global Healthcare Conference and Carnegie Nordic Virtual Healthcare Seminar Read more
March 10, 2021 Non Regulatory InDex Pharmaceuticals presenterar på Barclays Global Healthcare Conference och Carnegie Nordic Virtual Healthcare Seminar Read more